|
Market Closed -
NSE India S.E.
07:05:07 2026-09-08 EDT
|
5-day change | 1st Jan Change | ||
| 63.17 INR | +1.61% |
|
+0.70% | -18.69% |
Company Valuation: Alpa Laboratories Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 291.4 | 757.5 | 1,467 | 1,132 | 1,752 | 2,180 |
| Change | - | 159.93% | 93.61% | -22.81% | 54.74% | 24.44% |
| Enterprise Value (EV) 1 | -147.2 | 334.5 | 822.3 | 346.6 | 875.6 | 1,053 |
| Change | - | 327.25% | 145.84% | -57.85% | 152.61% | 20.26% |
| P/E | 15.7x | 10.5x | 10.4x | 9x | 10.4x | 11.2x |
| PBR | 0.29x | 0.7x | 1.2x | 0.84x | 1.15x | 1.27x |
| PEG | - | 0x | 0.1x | -0.8x | 0.3x | 0.7x |
| Capitalization / Revenue | 0.34x | 0.78x | 1.19x | 1.22x | 1.61x | 1.94x |
| EV / Revenue | -0.17x | 0.34x | 0.67x | 0.37x | 0.81x | 0.94x |
| EV / EBITDA | -2.51x | 3.87x | 3.83x | 4.28x | 10.2x | 22.4x |
| EV / EBIT | -3.12x | 4.52x | 4.16x | 5.13x | 13.2x | 42.1x |
| EV / FCF | -1.07x | -2.57x | 4.89x | 5.29x | -15.6x | 23.7x |
| FCF Yield | -93.6% | -38.9% | 20.4% | 18.9% | -6.4% | 4.22% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | 0.8809 | 3.444 | 6.697 | 5.98 | 7.973 | 9.269 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 859.7 | 975.5 | 1,230 | 929.6 | 1,087 | 1,125 |
| EBITDA 1 | 58.54 | 86.33 | 214.4 | 80.91 | 86.13 | 47.03 |
| EBIT 1 | 47.12 | 74.04 | 197.8 | 67.62 | 66.58 | 25.01 |
| Net income 1 | 18.53 | 72.47 | 140.9 | 125.8 | 167.8 | 195 |
| Net Debt 1 | -438.6 | -423 | -644.3 | -785.4 | -876.1 | -1,127 |
| Reference price 2 | 13.85 | 36.00 | 69.70 | 53.80 | 83.25 | 103.60 |
| Nbr of stocks (in thousands) | 21,041 | 21,041 | 21,041 | 21,041 | 21,041 | 21,041 |
| Announcement Date | 9/5/20 | 9/6/21 | 9/3/22 | 9/5/23 | 9/4/24 | 9/4/25 |
1INR in Million2INR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 13.83M | ||
| 34.97x | 6.57x | 22.76x | 0.9% | 48.08B | ||
| 16.83x | 2.08x | 9.26x | 1.53% | 39.95B | ||
| 27.16x | 3.29x | 17.07x | 0.93% | 11.92B | ||
| 27.74x | 3.96x | 16.4x | 0.58% | 12.2B | ||
| 18.88x | 3.36x | 11.68x | 3.82% | 9.22B | ||
| 9.31x | 2.14x | 5.53x | 4.65% | 7.41B | ||
| 15.6x | 2.04x | 6.78x | 3.23% | 7.37B | ||
| 29.82x | 3.9x | 18.16x | 0.16% | 7.32B | ||
| Average | 22.54x | 3.42x | 13.45x | 1.98% | 15.94B | |
| Weighted average by Cap. | 25.04x | 4.02x | 15.33x | 1.52% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ALPA Stock
- Valuation Alpa Laboratories Limited
Select your edition
All financial news and data tailored to specific country editions
















